Discover 514 paid clinical trials in Madison, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 514
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Madison WI, Grand Rapids MI, Hannibal MO,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT07082738
Phase2, Recruiting
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
for
Endometrial Cancer, Gastric Cancer,
Location: Madison WI, Grand Rapids MI, Cincinnati OH, Columbus OH,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT05489211
Phase2, Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for
Endometrial Cancer
Location: Madison WI, Arlington Heights IL, Evanston IL,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT06989112
Phase3, Recruiting
New
Interventions to Enhance Quadriceps Output After ACLR
for
ACL
Location: Madison WI
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 18 - 40
Code: NCT07674784
Recruiting
Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients
Get alerts for new trials in your area by subscribing now
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia,
Location: Madison WI, Milwaukee WI, Maywood IL, Chicago IL,
Sponsor: United Therapeutics
Sex: All
Age: 18+
Code: NCT06388421
Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Location: Madison WI, Chicago IL, Columbus OH, Nashville TN,
Sponsor: BlossomHill Therapeutics
Sex: All
Age: 18+
Code: NCT06501196
Phase1, Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: Madison WI, Chicago IL, Rochester MN, Grand Rapids MI,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06742996
Phase3, Recruiting
CAR-T Long Term Follow Up (LTFU) Study
for
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program,
Location: Madison WI, Chicago IL, Ann Arbor MI, Detroit MI,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 0 - 70+
Code: NCT02445222
Phase3, Recruiting
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies